|
|
| Phases of Development | Preclinical | Phase I | Phase I/II | Phase II | Phase III | Registration | Approved | Marketed |
|---|
| Cardiovascular | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | | Endocrine / Metabolic | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | | Genitourinary | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | | Inflammation | 1 | 2 | 0 | 5 | 4 | 3 | 1 | 9 | | Ophthalmic | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | | Pulmonary | 2 | 2 | 0 | 5 | 8 | 3 | 0 | 8 |
|
|
Products Targeting Adrenergic receptor beta 2 (ADRB2)